nodes	percent_of_prediction	percent_of_DWPC	metapath
Posaconazole—ABCB1—Dactinomycin—testicular cancer	0.0997	0.193	CbGbCtD
Posaconazole—CYP3A4—Ifosfamide—testicular cancer	0.0705	0.137	CbGbCtD
Posaconazole—ABCB1—Vinblastine—testicular cancer	0.0624	0.121	CbGbCtD
Posaconazole—ABCB1—Cisplatin—testicular cancer	0.0572	0.111	CbGbCtD
Posaconazole—ABCB1—Etoposide—testicular cancer	0.0562	0.109	CbGbCtD
Posaconazole—ABCB1—Doxorubicin—testicular cancer	0.0384	0.0744	CbGbCtD
Posaconazole—CYP3A4—Vinblastine—testicular cancer	0.0374	0.0725	CbGbCtD
Posaconazole—ABCB1—Methotrexate—testicular cancer	0.0372	0.0721	CbGbCtD
Posaconazole—CYP3A4—Etoposide—testicular cancer	0.0337	0.0653	CbGbCtD
Posaconazole—CYP3A4—Doxorubicin—testicular cancer	0.023	0.0446	CbGbCtD
Posaconazole—Conjunctivitis—Doxorubicin—testicular cancer	0.000152	0.000313	CcSEcCtD
Posaconazole—Urinary tract infection—Doxorubicin—testicular cancer	0.000152	0.000313	CcSEcCtD
Posaconazole—Hepatitis—Epirubicin—testicular cancer	0.000151	0.000312	CcSEcCtD
Posaconazole—Haemorrhage—Epirubicin—testicular cancer	0.000151	0.000312	CcSEcCtD
Posaconazole—Eye disorder—Methotrexate—testicular cancer	0.000151	0.000312	CcSEcCtD
Posaconazole—Tinnitus—Methotrexate—testicular cancer	0.000151	0.000311	CcSEcCtD
Posaconazole—Hypoaesthesia—Epirubicin—testicular cancer	0.000151	0.000311	CcSEcCtD
Posaconazole—Asthenia—Cisplatin—testicular cancer	0.00015	0.00031	CcSEcCtD
Posaconazole—Pharyngitis—Epirubicin—testicular cancer	0.00015	0.00031	CcSEcCtD
Posaconazole—Cardiac disorder—Methotrexate—testicular cancer	0.00015	0.00031	CcSEcCtD
Posaconazole—Urinary tract disorder—Epirubicin—testicular cancer	0.000149	0.000309	CcSEcCtD
Posaconazole—Oedema peripheral—Epirubicin—testicular cancer	0.000149	0.000308	CcSEcCtD
Posaconazole—Haematuria—Doxorubicin—testicular cancer	0.000149	0.000307	CcSEcCtD
Posaconazole—Connective tissue disorder—Epirubicin—testicular cancer	0.000149	0.000307	CcSEcCtD
Posaconazole—Urethral disorder—Epirubicin—testicular cancer	0.000148	0.000306	CcSEcCtD
Posaconazole—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000148	0.000305	CcSEcCtD
Posaconazole—Epistaxis—Doxorubicin—testicular cancer	0.000147	0.000304	CcSEcCtD
Posaconazole—Angiopathy—Methotrexate—testicular cancer	0.000147	0.000303	CcSEcCtD
Posaconazole—Sinusitis—Doxorubicin—testicular cancer	0.000146	0.000302	CcSEcCtD
Posaconazole—Immune system disorder—Methotrexate—testicular cancer	0.000146	0.000302	CcSEcCtD
Posaconazole—Mediastinal disorder—Methotrexate—testicular cancer	0.000146	0.000301	CcSEcCtD
Posaconazole—Agranulocytosis—Doxorubicin—testicular cancer	0.000146	0.0003	CcSEcCtD
Posaconazole—Chills—Methotrexate—testicular cancer	0.000145	0.0003	CcSEcCtD
Posaconazole—Nausea—Ifosfamide—testicular cancer	0.000144	0.000298	CcSEcCtD
Posaconazole—Diarrhoea—Cisplatin—testicular cancer	0.000143	0.000296	CcSEcCtD
Posaconazole—Erythema multiforme—Epirubicin—testicular cancer	0.000143	0.000295	CcSEcCtD
Posaconazole—Alopecia—Methotrexate—testicular cancer	0.000143	0.000295	CcSEcCtD
Posaconazole—Bradycardia—Doxorubicin—testicular cancer	0.000143	0.000294	CcSEcCtD
Posaconazole—Mental disorder—Methotrexate—testicular cancer	0.000142	0.000292	CcSEcCtD
Posaconazole—Eye disorder—Epirubicin—testicular cancer	0.000141	0.000292	CcSEcCtD
Posaconazole—Hypersensitivity—Etoposide—testicular cancer	0.000141	0.000292	CcSEcCtD
Posaconazole—Tinnitus—Epirubicin—testicular cancer	0.000141	0.000291	CcSEcCtD
Posaconazole—Erythema—Methotrexate—testicular cancer	0.000141	0.000291	CcSEcCtD
Posaconazole—Malnutrition—Methotrexate—testicular cancer	0.000141	0.000291	CcSEcCtD
Posaconazole—Haemoglobin—Doxorubicin—testicular cancer	0.000141	0.000291	CcSEcCtD
Posaconazole—Flushing—Epirubicin—testicular cancer	0.00014	0.00029	CcSEcCtD
Posaconazole—Cardiac disorder—Epirubicin—testicular cancer	0.00014	0.00029	CcSEcCtD
Posaconazole—Rhinitis—Doxorubicin—testicular cancer	0.00014	0.00029	CcSEcCtD
Posaconazole—Hepatitis—Doxorubicin—testicular cancer	0.00014	0.000289	CcSEcCtD
Posaconazole—Haemorrhage—Doxorubicin—testicular cancer	0.00014	0.000289	CcSEcCtD
Posaconazole—Hypoaesthesia—Doxorubicin—testicular cancer	0.000139	0.000288	CcSEcCtD
Posaconazole—Pharyngitis—Doxorubicin—testicular cancer	0.000139	0.000287	CcSEcCtD
Posaconazole—Urinary tract disorder—Doxorubicin—testicular cancer	0.000138	0.000285	CcSEcCtD
Posaconazole—Oedema peripheral—Doxorubicin—testicular cancer	0.000138	0.000285	CcSEcCtD
Posaconazole—Dysgeusia—Methotrexate—testicular cancer	0.000138	0.000285	CcSEcCtD
Posaconazole—Asthenia—Etoposide—testicular cancer	0.000138	0.000284	CcSEcCtD
Posaconazole—Connective tissue disorder—Doxorubicin—testicular cancer	0.000138	0.000284	CcSEcCtD
Posaconazole—Angiopathy—Epirubicin—testicular cancer	0.000137	0.000283	CcSEcCtD
Posaconazole—Urethral disorder—Doxorubicin—testicular cancer	0.000137	0.000283	CcSEcCtD
Posaconazole—Immune system disorder—Epirubicin—testicular cancer	0.000137	0.000282	CcSEcCtD
Posaconazole—Mediastinal disorder—Epirubicin—testicular cancer	0.000136	0.000282	CcSEcCtD
Posaconazole—Back pain—Methotrexate—testicular cancer	0.000136	0.000281	CcSEcCtD
Posaconazole—Chills—Epirubicin—testicular cancer	0.000136	0.00028	CcSEcCtD
Posaconazole—Pruritus—Etoposide—testicular cancer	0.000136	0.00028	CcSEcCtD
Posaconazole—Arrhythmia—Epirubicin—testicular cancer	0.000135	0.000279	CcSEcCtD
Posaconazole—Alopecia—Epirubicin—testicular cancer	0.000134	0.000276	CcSEcCtD
Posaconazole—Vomiting—Cisplatin—testicular cancer	0.000133	0.000275	CcSEcCtD
Posaconazole—Vision blurred—Methotrexate—testicular cancer	0.000133	0.000274	CcSEcCtD
Posaconazole—Mental disorder—Epirubicin—testicular cancer	0.000133	0.000274	CcSEcCtD
Posaconazole—Erythema multiforme—Doxorubicin—testicular cancer	0.000132	0.000273	CcSEcCtD
Posaconazole—Rash—Cisplatin—testicular cancer	0.000132	0.000272	CcSEcCtD
Posaconazole—Dermatitis—Cisplatin—testicular cancer	0.000132	0.000272	CcSEcCtD
Posaconazole—Erythema—Epirubicin—testicular cancer	0.000132	0.000272	CcSEcCtD
Posaconazole—Malnutrition—Epirubicin—testicular cancer	0.000132	0.000272	CcSEcCtD
Posaconazole—Diarrhoea—Etoposide—testicular cancer	0.000131	0.000271	CcSEcCtD
Posaconazole—Eye disorder—Doxorubicin—testicular cancer	0.000131	0.00027	CcSEcCtD
Posaconazole—Ill-defined disorder—Methotrexate—testicular cancer	0.000131	0.00027	CcSEcCtD
Posaconazole—Tinnitus—Doxorubicin—testicular cancer	0.000131	0.000269	CcSEcCtD
Posaconazole—Anaemia—Methotrexate—testicular cancer	0.00013	0.000269	CcSEcCtD
Posaconazole—Flushing—Doxorubicin—testicular cancer	0.00013	0.000268	CcSEcCtD
Posaconazole—Cardiac disorder—Doxorubicin—testicular cancer	0.00013	0.000268	CcSEcCtD
Posaconazole—Flatulence—Epirubicin—testicular cancer	0.00013	0.000268	CcSEcCtD
Posaconazole—Dysgeusia—Epirubicin—testicular cancer	0.000129	0.000266	CcSEcCtD
Posaconazole—Back pain—Epirubicin—testicular cancer	0.000127	0.000263	CcSEcCtD
Posaconazole—Angiopathy—Doxorubicin—testicular cancer	0.000127	0.000262	CcSEcCtD
Posaconazole—Malaise—Methotrexate—testicular cancer	0.000127	0.000262	CcSEcCtD
Posaconazole—Dizziness—Etoposide—testicular cancer	0.000127	0.000262	CcSEcCtD
Posaconazole—Muscle spasms—Epirubicin—testicular cancer	0.000127	0.000261	CcSEcCtD
Posaconazole—Immune system disorder—Doxorubicin—testicular cancer	0.000126	0.000261	CcSEcCtD
Posaconazole—Vertigo—Methotrexate—testicular cancer	0.000126	0.000261	CcSEcCtD
Posaconazole—Mediastinal disorder—Doxorubicin—testicular cancer	0.000126	0.000261	CcSEcCtD
Posaconazole—Leukopenia—Methotrexate—testicular cancer	0.000126	0.00026	CcSEcCtD
Posaconazole—Chills—Doxorubicin—testicular cancer	0.000126	0.000259	CcSEcCtD
Posaconazole—Arrhythmia—Doxorubicin—testicular cancer	0.000125	0.000258	CcSEcCtD
Posaconazole—Nausea—Cisplatin—testicular cancer	0.000124	0.000257	CcSEcCtD
Posaconazole—Vision blurred—Epirubicin—testicular cancer	0.000124	0.000256	CcSEcCtD
Posaconazole—Alopecia—Doxorubicin—testicular cancer	0.000124	0.000255	CcSEcCtD
Posaconazole—Cough—Methotrexate—testicular cancer	0.000123	0.000254	CcSEcCtD
Posaconazole—Mental disorder—Doxorubicin—testicular cancer	0.000123	0.000253	CcSEcCtD
Posaconazole—Ill-defined disorder—Epirubicin—testicular cancer	0.000122	0.000252	CcSEcCtD
Posaconazole—Convulsion—Methotrexate—testicular cancer	0.000122	0.000252	CcSEcCtD
Posaconazole—Vomiting—Etoposide—testicular cancer	0.000122	0.000252	CcSEcCtD
Posaconazole—Erythema—Doxorubicin—testicular cancer	0.000122	0.000252	CcSEcCtD
Posaconazole—Malnutrition—Doxorubicin—testicular cancer	0.000122	0.000252	CcSEcCtD
Posaconazole—Anaemia—Epirubicin—testicular cancer	0.000122	0.000251	CcSEcCtD
Posaconazole—Agitation—Epirubicin—testicular cancer	0.000121	0.00025	CcSEcCtD
Posaconazole—Rash—Etoposide—testicular cancer	0.000121	0.00025	CcSEcCtD
Posaconazole—Dermatitis—Etoposide—testicular cancer	0.000121	0.000249	CcSEcCtD
Posaconazole—Headache—Etoposide—testicular cancer	0.00012	0.000248	CcSEcCtD
Posaconazole—Flatulence—Doxorubicin—testicular cancer	0.00012	0.000248	CcSEcCtD
Posaconazole—Arthralgia—Methotrexate—testicular cancer	0.00012	0.000247	CcSEcCtD
Posaconazole—Chest pain—Methotrexate—testicular cancer	0.00012	0.000247	CcSEcCtD
Posaconazole—Myalgia—Methotrexate—testicular cancer	0.00012	0.000247	CcSEcCtD
Posaconazole—Dysgeusia—Doxorubicin—testicular cancer	0.000119	0.000246	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000119	0.000246	CcSEcCtD
Posaconazole—Malaise—Epirubicin—testicular cancer	0.000119	0.000245	CcSEcCtD
Posaconazole—Discomfort—Methotrexate—testicular cancer	0.000118	0.000244	CcSEcCtD
Posaconazole—Vertigo—Epirubicin—testicular cancer	0.000118	0.000244	CcSEcCtD
Posaconazole—Syncope—Epirubicin—testicular cancer	0.000118	0.000244	CcSEcCtD
Posaconazole—Leukopenia—Epirubicin—testicular cancer	0.000118	0.000243	CcSEcCtD
Posaconazole—Back pain—Doxorubicin—testicular cancer	0.000118	0.000243	CcSEcCtD
Posaconazole—Muscle spasms—Doxorubicin—testicular cancer	0.000117	0.000242	CcSEcCtD
Posaconazole—Confusional state—Methotrexate—testicular cancer	0.000116	0.000239	CcSEcCtD
Posaconazole—Loss of consciousness—Epirubicin—testicular cancer	0.000116	0.000239	CcSEcCtD
Posaconazole—Cough—Epirubicin—testicular cancer	0.000115	0.000237	CcSEcCtD
Posaconazole—Vision blurred—Doxorubicin—testicular cancer	0.000115	0.000237	CcSEcCtD
Posaconazole—Convulsion—Epirubicin—testicular cancer	0.000114	0.000236	CcSEcCtD
Posaconazole—Infection—Methotrexate—testicular cancer	0.000114	0.000236	CcSEcCtD
Posaconazole—Nausea—Etoposide—testicular cancer	0.000114	0.000235	CcSEcCtD
Posaconazole—Hypertension—Epirubicin—testicular cancer	0.000114	0.000235	CcSEcCtD
Posaconazole—Ill-defined disorder—Doxorubicin—testicular cancer	0.000113	0.000233	CcSEcCtD
Posaconazole—Nervous system disorder—Methotrexate—testicular cancer	0.000113	0.000233	CcSEcCtD
Posaconazole—Anaemia—Doxorubicin—testicular cancer	0.000113	0.000233	CcSEcCtD
Posaconazole—Thrombocytopenia—Methotrexate—testicular cancer	0.000112	0.000232	CcSEcCtD
Posaconazole—Myalgia—Epirubicin—testicular cancer	0.000112	0.000232	CcSEcCtD
Posaconazole—Chest pain—Epirubicin—testicular cancer	0.000112	0.000232	CcSEcCtD
Posaconazole—Arthralgia—Epirubicin—testicular cancer	0.000112	0.000232	CcSEcCtD
Posaconazole—Agitation—Doxorubicin—testicular cancer	0.000112	0.000231	CcSEcCtD
Posaconazole—Anxiety—Epirubicin—testicular cancer	0.000112	0.000231	CcSEcCtD
Posaconazole—Skin disorder—Methotrexate—testicular cancer	0.000112	0.00023	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000111	0.00023	CcSEcCtD
Posaconazole—Hyperhidrosis—Methotrexate—testicular cancer	0.000111	0.000229	CcSEcCtD
Posaconazole—Discomfort—Epirubicin—testicular cancer	0.000111	0.000229	CcSEcCtD
Posaconazole—Malaise—Doxorubicin—testicular cancer	0.00011	0.000227	CcSEcCtD
Posaconazole—Dry mouth—Epirubicin—testicular cancer	0.00011	0.000226	CcSEcCtD
Posaconazole—Vertigo—Doxorubicin—testicular cancer	0.00011	0.000226	CcSEcCtD
Posaconazole—Anorexia—Methotrexate—testicular cancer	0.00011	0.000226	CcSEcCtD
Posaconazole—Syncope—Doxorubicin—testicular cancer	0.000109	0.000226	CcSEcCtD
Posaconazole—Leukopenia—Doxorubicin—testicular cancer	0.000109	0.000225	CcSEcCtD
Posaconazole—Confusional state—Epirubicin—testicular cancer	0.000108	0.000224	CcSEcCtD
Posaconazole—Oedema—Epirubicin—testicular cancer	0.000108	0.000222	CcSEcCtD
Posaconazole—Hypotension—Methotrexate—testicular cancer	0.000107	0.000222	CcSEcCtD
Posaconazole—Loss of consciousness—Doxorubicin—testicular cancer	0.000107	0.000221	CcSEcCtD
Posaconazole—Infection—Epirubicin—testicular cancer	0.000107	0.00022	CcSEcCtD
Posaconazole—Cough—Doxorubicin—testicular cancer	0.000106	0.00022	CcSEcCtD
Posaconazole—Shock—Epirubicin—testicular cancer	0.000106	0.000218	CcSEcCtD
Posaconazole—Convulsion—Doxorubicin—testicular cancer	0.000106	0.000218	CcSEcCtD
Posaconazole—Nervous system disorder—Epirubicin—testicular cancer	0.000105	0.000218	CcSEcCtD
Posaconazole—Thrombocytopenia—Epirubicin—testicular cancer	0.000105	0.000217	CcSEcCtD
Posaconazole—Hypertension—Doxorubicin—testicular cancer	0.000105	0.000217	CcSEcCtD
Posaconazole—Tachycardia—Epirubicin—testicular cancer	0.000105	0.000217	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000105	0.000216	CcSEcCtD
Posaconazole—Skin disorder—Epirubicin—testicular cancer	0.000104	0.000216	CcSEcCtD
Posaconazole—Hyperhidrosis—Epirubicin—testicular cancer	0.000104	0.000215	CcSEcCtD
Posaconazole—Insomnia—Methotrexate—testicular cancer	0.000104	0.000215	CcSEcCtD
Posaconazole—Myalgia—Doxorubicin—testicular cancer	0.000104	0.000214	CcSEcCtD
Posaconazole—Chest pain—Doxorubicin—testicular cancer	0.000104	0.000214	CcSEcCtD
Posaconazole—Arthralgia—Doxorubicin—testicular cancer	0.000104	0.000214	CcSEcCtD
Posaconazole—Anxiety—Doxorubicin—testicular cancer	0.000103	0.000213	CcSEcCtD
Posaconazole—Paraesthesia—Methotrexate—testicular cancer	0.000103	0.000213	CcSEcCtD
Posaconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000103	0.000213	CcSEcCtD
Posaconazole—Discomfort—Doxorubicin—testicular cancer	0.000103	0.000212	CcSEcCtD
Posaconazole—Anorexia—Epirubicin—testicular cancer	0.000102	0.000212	CcSEcCtD
Posaconazole—Dyspnoea—Methotrexate—testicular cancer	0.000102	0.000211	CcSEcCtD
Posaconazole—Somnolence—Methotrexate—testicular cancer	0.000102	0.000211	CcSEcCtD
Posaconazole—Dry mouth—Doxorubicin—testicular cancer	0.000101	0.00021	CcSEcCtD
Posaconazole—Dyspepsia—Methotrexate—testicular cancer	0.000101	0.000209	CcSEcCtD
Posaconazole—Hypotension—Epirubicin—testicular cancer	0.0001	0.000207	CcSEcCtD
Posaconazole—Confusional state—Doxorubicin—testicular cancer	0.0001	0.000207	CcSEcCtD
Posaconazole—Decreased appetite—Methotrexate—testicular cancer	9.99e-05	0.000206	CcSEcCtD
Posaconazole—Oedema—Doxorubicin—testicular cancer	9.95e-05	0.000205	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Methotrexate—testicular cancer	9.92e-05	0.000205	CcSEcCtD
Posaconazole—Fatigue—Methotrexate—testicular cancer	9.9e-05	0.000204	CcSEcCtD
Posaconazole—Infection—Doxorubicin—testicular cancer	9.88e-05	0.000204	CcSEcCtD
Posaconazole—Pain—Methotrexate—testicular cancer	9.82e-05	0.000203	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Epirubicin—testicular cancer	9.79e-05	0.000202	CcSEcCtD
Posaconazole—Shock—Doxorubicin—testicular cancer	9.79e-05	0.000202	CcSEcCtD
Posaconazole—Nervous system disorder—Doxorubicin—testicular cancer	9.76e-05	0.000201	CcSEcCtD
Posaconazole—Thrombocytopenia—Doxorubicin—testicular cancer	9.74e-05	0.000201	CcSEcCtD
Posaconazole—Insomnia—Epirubicin—testicular cancer	9.72e-05	0.000201	CcSEcCtD
Posaconazole—Tachycardia—Doxorubicin—testicular cancer	9.71e-05	0.0002	CcSEcCtD
Posaconazole—Skin disorder—Doxorubicin—testicular cancer	9.66e-05	0.000199	CcSEcCtD
Posaconazole—Paraesthesia—Epirubicin—testicular cancer	9.65e-05	0.000199	CcSEcCtD
Posaconazole—Hyperhidrosis—Doxorubicin—testicular cancer	9.62e-05	0.000199	CcSEcCtD
Posaconazole—Dyspnoea—Epirubicin—testicular cancer	9.58e-05	0.000198	CcSEcCtD
Posaconazole—Somnolence—Epirubicin—testicular cancer	9.56e-05	0.000197	CcSEcCtD
Posaconazole—Anorexia—Doxorubicin—testicular cancer	9.48e-05	0.000196	CcSEcCtD
Posaconazole—Feeling abnormal—Methotrexate—testicular cancer	9.47e-05	0.000195	CcSEcCtD
Posaconazole—Dyspepsia—Epirubicin—testicular cancer	9.46e-05	0.000195	CcSEcCtD
Posaconazole—Gastrointestinal pain—Methotrexate—testicular cancer	9.39e-05	0.000194	CcSEcCtD
Posaconazole—Decreased appetite—Epirubicin—testicular cancer	9.35e-05	0.000193	CcSEcCtD
Posaconazole—Hypotension—Doxorubicin—testicular cancer	9.3e-05	0.000192	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Epirubicin—testicular cancer	9.28e-05	0.000192	CcSEcCtD
Posaconazole—Fatigue—Epirubicin—testicular cancer	9.27e-05	0.000191	CcSEcCtD
Posaconazole—Pain—Epirubicin—testicular cancer	9.19e-05	0.00019	CcSEcCtD
Posaconazole—Constipation—Epirubicin—testicular cancer	9.19e-05	0.00019	CcSEcCtD
Posaconazole—Urticaria—Methotrexate—testicular cancer	9.13e-05	0.000188	CcSEcCtD
Posaconazole—Body temperature increased—Methotrexate—testicular cancer	9.08e-05	0.000187	CcSEcCtD
Posaconazole—Abdominal pain—Methotrexate—testicular cancer	9.08e-05	0.000187	CcSEcCtD
Posaconazole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	9.06e-05	0.000187	CcSEcCtD
Posaconazole—Insomnia—Doxorubicin—testicular cancer	9e-05	0.000186	CcSEcCtD
Posaconazole—Paraesthesia—Doxorubicin—testicular cancer	8.93e-05	0.000184	CcSEcCtD
Posaconazole—Dyspnoea—Doxorubicin—testicular cancer	8.87e-05	0.000183	CcSEcCtD
Posaconazole—Feeling abnormal—Epirubicin—testicular cancer	8.86e-05	0.000183	CcSEcCtD
Posaconazole—Somnolence—Doxorubicin—testicular cancer	8.84e-05	0.000183	CcSEcCtD
Posaconazole—Gastrointestinal pain—Epirubicin—testicular cancer	8.79e-05	0.000181	CcSEcCtD
Posaconazole—Dyspepsia—Doxorubicin—testicular cancer	8.76e-05	0.000181	CcSEcCtD
Posaconazole—Decreased appetite—Doxorubicin—testicular cancer	8.65e-05	0.000179	CcSEcCtD
Posaconazole—Gastrointestinal disorder—Doxorubicin—testicular cancer	8.59e-05	0.000177	CcSEcCtD
Posaconazole—Fatigue—Doxorubicin—testicular cancer	8.58e-05	0.000177	CcSEcCtD
Posaconazole—Urticaria—Epirubicin—testicular cancer	8.54e-05	0.000176	CcSEcCtD
Posaconazole—Constipation—Doxorubicin—testicular cancer	8.51e-05	0.000176	CcSEcCtD
Posaconazole—Pain—Doxorubicin—testicular cancer	8.51e-05	0.000176	CcSEcCtD
Posaconazole—Body temperature increased—Epirubicin—testicular cancer	8.5e-05	0.000175	CcSEcCtD
Posaconazole—Abdominal pain—Epirubicin—testicular cancer	8.5e-05	0.000175	CcSEcCtD
Posaconazole—Hypersensitivity—Methotrexate—testicular cancer	8.46e-05	0.000175	CcSEcCtD
Posaconazole—Asthenia—Methotrexate—testicular cancer	8.24e-05	0.00017	CcSEcCtD
Posaconazole—Feeling abnormal—Doxorubicin—testicular cancer	8.2e-05	0.000169	CcSEcCtD
Posaconazole—Gastrointestinal pain—Doxorubicin—testicular cancer	8.13e-05	0.000168	CcSEcCtD
Posaconazole—Pruritus—Methotrexate—testicular cancer	8.13e-05	0.000168	CcSEcCtD
Posaconazole—Hypersensitivity—Epirubicin—testicular cancer	7.92e-05	0.000164	CcSEcCtD
Posaconazole—Urticaria—Doxorubicin—testicular cancer	7.9e-05	0.000163	CcSEcCtD
Posaconazole—Abdominal pain—Doxorubicin—testicular cancer	7.86e-05	0.000162	CcSEcCtD
Posaconazole—Body temperature increased—Doxorubicin—testicular cancer	7.86e-05	0.000162	CcSEcCtD
Posaconazole—Diarrhoea—Methotrexate—testicular cancer	7.86e-05	0.000162	CcSEcCtD
Posaconazole—Asthenia—Epirubicin—testicular cancer	7.71e-05	0.000159	CcSEcCtD
Posaconazole—Pruritus—Epirubicin—testicular cancer	7.61e-05	0.000157	CcSEcCtD
Posaconazole—Dizziness—Methotrexate—testicular cancer	7.6e-05	0.000157	CcSEcCtD
Posaconazole—Diarrhoea—Epirubicin—testicular cancer	7.36e-05	0.000152	CcSEcCtD
Posaconazole—Hypersensitivity—Doxorubicin—testicular cancer	7.33e-05	0.000151	CcSEcCtD
Posaconazole—Vomiting—Methotrexate—testicular cancer	7.3e-05	0.000151	CcSEcCtD
Posaconazole—Rash—Methotrexate—testicular cancer	7.24e-05	0.00015	CcSEcCtD
Posaconazole—Dermatitis—Methotrexate—testicular cancer	7.24e-05	0.000149	CcSEcCtD
Posaconazole—Headache—Methotrexate—testicular cancer	7.2e-05	0.000149	CcSEcCtD
Posaconazole—Asthenia—Doxorubicin—testicular cancer	7.14e-05	0.000147	CcSEcCtD
Posaconazole—Dizziness—Epirubicin—testicular cancer	7.11e-05	0.000147	CcSEcCtD
Posaconazole—Pruritus—Doxorubicin—testicular cancer	7.04e-05	0.000145	CcSEcCtD
Posaconazole—Vomiting—Epirubicin—testicular cancer	6.84e-05	0.000141	CcSEcCtD
Posaconazole—Nausea—Methotrexate—testicular cancer	6.82e-05	0.000141	CcSEcCtD
Posaconazole—Diarrhoea—Doxorubicin—testicular cancer	6.81e-05	0.000141	CcSEcCtD
Posaconazole—Rash—Epirubicin—testicular cancer	6.78e-05	0.00014	CcSEcCtD
Posaconazole—Dermatitis—Epirubicin—testicular cancer	6.77e-05	0.00014	CcSEcCtD
Posaconazole—Headache—Epirubicin—testicular cancer	6.73e-05	0.000139	CcSEcCtD
Posaconazole—Dizziness—Doxorubicin—testicular cancer	6.58e-05	0.000136	CcSEcCtD
Posaconazole—Nausea—Epirubicin—testicular cancer	6.39e-05	0.000132	CcSEcCtD
Posaconazole—Vomiting—Doxorubicin—testicular cancer	6.32e-05	0.000131	CcSEcCtD
Posaconazole—Rash—Doxorubicin—testicular cancer	6.27e-05	0.000129	CcSEcCtD
Posaconazole—Dermatitis—Doxorubicin—testicular cancer	6.27e-05	0.000129	CcSEcCtD
Posaconazole—Headache—Doxorubicin—testicular cancer	6.23e-05	0.000129	CcSEcCtD
Posaconazole—Nausea—Doxorubicin—testicular cancer	5.91e-05	0.000122	CcSEcCtD
